These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9921800)

  • 1. Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation.
    Gane EJ; Maertens G; Ducatteeuw A; Qian KP; Lau JY; Jones H; Davies E; Naoumov NV; Williams R
    Transplantation; 1999 Jan; 67(1):78-84. PubMed ID: 9921800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.
    Bassett SE; Thomas DL; Brasky KM; Lanford RE
    J Virol; 1999 Feb; 73(2):1118-26. PubMed ID: 9882313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
    Santos VCD; Schinoni MI; Oliveira IS; Atta MLS; Atta AM
    Rev Soc Bras Med Trop; 2019 Mar; 52():e20180491. PubMed ID: 30843970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological pattern of hepatitis C virus recurrence after liver transplantation.
    Rehermann B; Seifert U; Tillmann HL; Michel G; Böker KH; Pichlmayr R; Manns MP
    J Hepatol; 1996 Jan; 24(1):15-20. PubMed ID: 8834019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens.
    Papatheodoridis GV; Barton SG; Andrew D; Clewley G; Davies S; Dhillon AP; Dusheiko G; Davidson B; Rolles K; Burroughs AK
    Gut; 1999 Sep; 45(3):427-34. PubMed ID: 10446114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
    Rosa D; Campagnoli S; Moretto C; Guenzi E; Cousens L; Chin M; Dong C; Weiner AJ; Lau JY; Choo QL; Chien D; Pileri P; Houghton M; Abrignani S
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1759-63. PubMed ID: 8700831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.
    Zampino R; Marrone A; Durante Mangoni E; Santarpia L; Sica A; Tripodi MF; Utili R; Ruggiero G; Adinolfi LE
    J Med Virol; 2004 May; 73(1):33-7. PubMed ID: 15042645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C.
    Fournillier-Jacob A; Lunel F; Cahour A; Cresta P; Frangeul L; Perrin M; Girard M; Wychowski C
    J Med Virol; 1996 Oct; 50(2):159-67. PubMed ID: 8915882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal transmission of hepatitis C antigens: envelope 1, envelope 2 and non-structural 4.
    Attallah AM; Abdallah SO; El-Far M; Omran MM; Tabll AA; Ghaly MF; Ezzat SM; Elhamshary MO; El-Gohary ZM; Mohamedin AH; El-Morsi AA; Askora AA; Abdelrazek MA; El-Kafrawy HM; Keneber MH; Khalil MR; Aggag MM; Elbendary MS; El-Deeb MM; Abuzaid MS; Mansour AT; Attallah AA
    Infect Dis (Lond); 2015 Aug; 47(8):568-74. PubMed ID: 25922972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal analysis of hepatitis C virus replication following liver transplantation.
    Gane EJ; Naoumov NV; Qian KP; Mondelli MU; Maertens G; Portmann BC; Lau JY; Williams R
    Gastroenterology; 1996 Jan; 110(1):167-77. PubMed ID: 8536853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.